P. A. Baumann

Novartis (Switzerland) — Switzerland

Neuroscience · Life Sciences

13h-index805citations20works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(9), Neurotransmitter Receptor Influence on Behavior(8), Receptor Mechanisms and Signaling(5), Epilepsy research and treatment(4), Pharmacological Effects and Toxicity Studies(3)

Publications20 total

Characterization of a New, Short-Acting and Specific Inhibitor of Type A Monoamine Oxidase
Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry·2015· 36 cited
ChemInform Abstract: Phosphinic Acid Analogues of GABA. Part 2. Selective, Orally Active GABAB Antagonists.
ChemInform·1995· 5 cited
ChemInform Abstract: Phosphinic Acid Analogues of GABA. Part 1. New Potent and Selective GABAB Agonists.
ChemInform·1995· 15 cited
Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters
Neurology·1995· 131 cited
A role for computer simulation in solving the riddles of autoreceptor-mediated regulation of GABA release
Naunyn-Schmiedeberg s Archives of Pharmacology·1993· 2 cited
CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure
Naunyn-Schmiedeberg s Archives of Pharmacology·1990· 40 cited
Investigations on GABAB receptor-mediated autoinhibition of GABA release
Naunyn-Schmiedeberg s Archives of Pharmacology·1990· 41 cited
The measurement of the release of endogenous GABA from rat brain slices by liquid chromatography with electrochemical detection
Naunyn-Schmiedeberg s Archives of Pharmacology·1988· 21 cited
On the Interaction Carbamazepine with Catecholamine Metabolism: Implication for Psychopharmacological and Behavioural Effects
1985· 1 cited
Carbamazepine decreases catecholamine turnover in the rat brain.
Journal of Pharmacology and Experimental Therapeutics·1984· 31 cited
CGP 15 210 G, AN UNUSUAL INHIBITOR OF SEROTONIN (5-HT) UPTAKE
Clinical Neuropharmacology·1984· 2 cited
Negative feedback control of serotonin release in vivo: Comparison of 5-hydroxyindolacetic acid levels measured by voltammetry in conscious rats and by biochemical techniques
Neuroscience·1984· 38 cited
Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer
Biochemical Pharmacology·1982· 99 cited
5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity.
PubMed·1982· 27 cited
CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
Journal of Pharmacology and Experimental Therapeutics·1979· 57 cited
Neurobiochemical Aspects of Maprotiline (Ludiomil®) Action
Journal of International Medical Research·1979· 34 cited
Metaraminol uptake by human thrombocytes: A poor model for neuronal noradrenaline uptake
Cellular and Molecular Life Sciences·1977· 1 cited
Blockade of presynaptic ?-receptors and of amine uptake in the rat brain by the antidepressant mianserine
Naunyn-Schmiedeberg s Archives of Pharmacology·1977· 208 cited
Effects of some tetrahydrocannabinols on the biosynthesis and utilisation of catecholamines in the rat brain
Biochemical Pharmacology·1974· 8 cited
Effects of some tetrahydrocannabinols on the biosynthesis and utilization of catecholamines in the rat brain
Life Sciences·1973· 8 cited

Frequent Co-authors

P. C. Waldmeier(17), L. Maître(10), Kathleen Hauser(4), Peter Wicki(3), J.-J. Feldtrauer(3), H. Bittiger(3), G. VON SPRECHER(3), Christine Stierlin(2), Markus Schmutz(2), A. Delini‐Stula(2), P. de Herdt(2), Wolfgang Froestl(2), Stuart J. Mickel(2), Roger G. Hall(2), Dietrich Strub(2), C. Gentsch(2), Joachim Jaekel(2), A. Vassout(2), L. Ma�tre(1), A. Storni(1)